Sign Up to like & get
recommendations!
2
Published in 2022 at "European heart journal"
DOI: 10.1093/eurheartj/ehac444
Abstract: AIMS Hyperlipidaemia and inflammation jointly contribute to atherosclerotic disease. Yet, after the initiation of statin therapy, the relative contributions of these processes may differ in patient groups, such as those with and without impaired kidney…
read more here.
Keywords:
ldl non;
disease;
non hdl;
risk ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Circulation"
DOI: 10.1161/circulationaha.119.042776
Abstract: Circulation. 2019;140:e822–e823. DOI: 10.1161/CIRCULATIONAHA.119.042776 e822 Allan D. Sniderman, MD George Thanassoulis, MD, MSc Michael Pencina, PhD To the Editor: In their study of the UK Biobank database, Welsh et al1 concluded that “measurement of total…
read more here.
Keywords:
ldl non;
cardiovascular disease;
cvd;
risk ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Aging and Disease"
DOI: 10.14336/ad.2019.1025
Abstract: Understanding how blood lipid levels change with age in the general population is a precondition to defining dyslipidemia. To explore age-related trends in LDL-C and non-HDL-C levels in the general population, a large-scale cross-sectional study…
read more here.
Keywords:
ldl non;
hdl levels;
non hdl;
age ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2021.674446
Abstract: Background: Xuezhikang, an extract of red yeast rice, effectively lowers fasting blood lipid levels. However, the influence of Xuezhikang on the non-fasting levels of low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C) has not…
read more here.
Keywords:
non fasting;
ldl non;
non hdl;
xuezhikang ... See more keywords